Increasing evidence suggests that insulin dysfunction and high glycemic variability in the central nervous system (CNS) play a pivotal role in neurodegenerative disorders, such as Alzheimer’s disease (AD), giving rise to the concept of “Type 3 diabetes” [10]. Here, INS is linked to Alzheimer disease.